BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12088576)

  • 1. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
    Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
    J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
    Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
    Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
    Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
    J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant vaccination against hepatitis A and typhoid fever.
    Van Hoecke C; Lebacq E; Beran J; Prymula R; Collard F
    J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
    Van Herck K; Van Damme P; Collard F; Thoelen S
    Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
    Burgess MA; Rodger AJ; Waite SA; Collard F
    Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
    Beran J; Chlibek R; Weber F
    Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 18. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
    Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
    J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
    Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
    Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.